HARBIN PHARMACEUTICAL GROUP CO., LTD.

Consensus Harbin Pharmaceutical Group Co., Ltd.

Stocks

600664

CNE0000009T3

Pharmaceuticals

End-of-day quote Shanghai S.E. 2026-09-18			5-day change	1st Jan Change
7.500 ^CNY	+1.08%		+7.30%	+117.39%

08-25	Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-04	Harbin Pharma's Two Drugs Recommended for China's Centralized Drug Procurement Listing	MT

Evolution of the Average Target: Harbin Pharmaceutical Group Co., Ltd.

Evolution of the Target Price: Harbin Pharmaceutical Group Co., Ltd.

Changes in Analyst Recommendations: Harbin Pharmaceutical Group Co., Ltd.

e6aa2274d0f9978e5.cMcynXMqzBCbKcuHKlhGMt-83U5Lyi1KSzN-1tXt0uA.QYFq2xB1hyDXao3-BwELbbDbqh0g-1QaL38sh6y_p5QhoAewEES1cvZQuA~59392b0aa291e10789d39ac7a2f3289c

Other Pharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	HARBIN PHARMACEUTICAL GROUP CO., LTD.			-	-	+22.13%
	ELI LILLY AND COMPANY					+14.96%
	JOHNSON & JOHNSON					+2.93%
	ABBVIE INC.					+5.55%
	ROCHE HOLDING AG					+5.2%
	NOVARTIS AG					+9.33%
	ASTRAZENECA PLC					+26.46%
	AMGEN INC.					+0.53%
	NOVO NORDISK A/S					+10.16%
	GILEAD SCIENCES, INC.					+5.35%
	Average					+10.26%
	Weighted average by Cap.					+9.47%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

7.500CNY

Average target price

9.160CNY

Spread / Average Target

+22.13%

High Price Target

9.160CNY

Spread / Highest target

+22.13%

Low Price Target

9.160CNY

Spread / Lowest Target

+22.13%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
600664 Stock
Consensus Harbin Pharmaceutical Group Co., Ltd.

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!